Skip to Content

JSP 515 (Levothyroxine 75 mcg (0.075 mg))

Pill imprint JSP 515 has been identified as Levothyroxine sodium 75 mcg (0.075 mg).

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 75 mcg (0.075 mg) is not a controlled substance under the Controlled Substance Act (CSA).

Levothyroxine sodium 75 mcg (0.075 mg) JSP 515
Levothyroxine sodium 75 mcg (0.075 mg) JSP 515 Front
Levothyroxine sodium 75 mcg (0.075 mg) JSP 515 Back
Discount Card Promo
Levothyroxine sodium
JSP 515
75 mcg (0.075 mg)
7.00 mm
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Lannett Company, Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
FD&C Red No. 40
FD&C Blue No. 2
aluminum oxide

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00527-1372 Lannett Company, Inc.
00527-1372 Lannett Company, Inc.
66336-0849 Dispensing Solutions Inc. (repackager)
21695-0750 Rebel Distributors Corp (repackager)
54868-2539 Physicians Total Care Inc (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.